UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) February 27, 2008
-----------------
Kewaunee Scientific Corporation
--------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
--------------------------------------------------------------------------------
Delaware 0-5286 38-0715562
(State or other jurisdiction (Commission (I.R.S. Employer
of incorporation) File Number) Identification No.)
--------------------------------------------------------------------------------
2700 West Front Street 28677
Statesville, North Carolina (Zip Code)
(Address of principal executive offices)
Registrant's telephone number, including area code 704-873-7202
--------------------------------------------------------------------------------
N/A
(Former name or former address, if changed since last report.)
--------------------------------------------------------------------------------
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
|_| Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
|_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|_| Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
|_| Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13a-4(c))
Item 2.02 Results of Operations and Financial Conditions
On February 27, 2008, Kewaunee Scientific Corporation issued a press release
announcing its financial results for the third quarter ended January 31, 2008. A
copy of the Press Release is furnished as Exhibit 99.1 to this Current Report on
Form 8-K.
Item 9.01 Financial Statements and Exhibits
(c) Exhibits:
Exhibit No.
99.1 Press Release of Kewaunee Scientific Corporation dated February 27,
2008
In accordance with General Instruction B.2 of Form 8-K, the information in this
Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed "filed"
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended
(the "Exchange Act"), or otherwise subject to the liabilities of that section,
and shall not be incorporated by reference into any registration statement or
other document filed under the Securities Act of 1933, as amended, or the
Exchange Act, except as shall be expressly set forth by specific reference in
such filing.
Signature
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
(Registrant)
Kewaunee Scientific Corporation
Date: February 27, 2008 /s/ D. Michael Parker
------------------------------
Senior Vice President, Finance
Chief Financial Officer